Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter Klaus Marschel currently holds 3,900 shares of Decoy Therapeutics Inc. (DCOY), valued at approximately $0. This represents their equity stake as Chief Business Officer.
Based on SEC Form 4 filings, Peter Klaus Marschel has been a net neutral trader of DCOY stock. They have purchased $0 and sold $0 worth of shares.
Peter Klaus Marschel's most recent insider trade was on Aug 31, 2026, when they sold 3,900 shares at $0.00 per share.
Peter Klaus Marschel serves as Chief Business Officer at Decoy Therapeutics Inc. (DCOY). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Peter Klaus Marschel holds the position of Chief Business Officer at Decoy Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Peter Klaus Marschel has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Peter Klaus Marschel was on Aug 31, 2026, when they purchased $0 worth of DCOY shares. This transaction involved 3,900 shares at N/A per share.
Peter Klaus Marschel currently owns 3,900 shares of Decoy Therapeutics Inc. (DCOY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter Klaus Marschel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter Klaus Marschel has 1 Form 4 filings on record as an insider at Decoy Therapeutics Inc..
Set alerts for Peter Klaus Marschel and 40,000+ other insiders.